Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome

Medical Hypotheses

Volumn 70, Issue 2, 2008, Pages 269-272

  Khan, S ^a,b   Holding, S ^b   Dore P C ^b   Sewell, W A C ^a,c  

^a SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LEUKOSIALIN; N ACETYLGLUCOSAMINYLTRANSFERASE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR FOXP3; WISKOTT ALDRICH SYNDROME PROTEIN;

ACTIN POLYMERIZATION; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL MATURATION; CELLULAR STRESS RESPONSE; CLINICAL FEATURE; CYTOSKELETON; DISEASE COURSE; ENZYME ACTIVITY; GENE MUTATION; HEMATOPOIETIC CELL; HUMAN; LYMPHOCYTOPENIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; REGULATORY T LYMPHOCYTE; SYMPTOM; T LYMPHOCYTE; WISKOTT ALDRICH SYNDROME; X CHROMOSOME;

ANTIGENS, CD43; AUTOIMMUNITY; GLYCOSYLATION; HUMANS; LYMPHOPENIA; MALE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; WISKOTT-ALDRICH SYNDROME;

EID: 37349049916     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.05.048     Document Type: Article

References (33)

1. Notarangelo L.D., Notarangelo L.D., and Ochs H.D. WASP and the phenotypic range associated with deficiency. Curr Opin Allergy Clin Immunol 5 6 (2005) 485-490
2. Imai K., Morio T., Zhu Y., et al. Clinical course of patients with WASP gene mutations. Blood 103 2 (2004) 456-464
3. Humblet-Baron S., Sather B., Anover S., et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest 117 2 (2007) 407-418
4. Maillard M.H., Cotta-de-Almeida V., Takeshima F., et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 204 2 (2007) 381-391
5. Rawlings S.L., Crooks G.M., Bockstoce D., Barsky L.W., Parkman R., and Weinberg K.I. Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression. Blood 94 11 (1999) 3872-3882
6. Rengan R., Ochs H.D., Sweet L.I., et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood 95 4 (2000) 1283-1292
7. Wada T., Schurman S.H., Garabedian E.K., Yachie A., and Candotti F. Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome. Blood 106 12 (2005) 3895-3897
8. Piller F., Le Deist F., Weinberg K.I., Parkman R., and Fukuda M. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. J Exp Med 173 6 (1991) 1501-1510
9. Higgins E.A., Siminovitch K.A., Zhuang D.L., Brockhausen I., and Dennis J.W. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J Biol Chem 266 10 (1991) 6280-6290
10. Bleesing J.J., Brown M.R., Dale J.K., et al. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol 100 3 (2001) 314-324
11. Matsumoto M., Atarashi K., Umemoto E., et al. CD43 functions as a ligand for E-Selectin on activated T cells. J Immunol 175 12 (2005) 8042-8050
12. Rosenstein Y., Park J.K., Hahn W.C., Rosen F.S., Bierer B.E., and Burakoff S.J. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 354 6350 (1991) 233-235
13. Cruz-Munoz M.E., Salas-Vidal E., Salaiza-Suazo N., Becker I., Pedraza-Alva G., and Rosenstein Y. The CD43 coreceptor molecule recruits the zeta-chain as part of its signalling pathway. J Immunol 171 4 (2003) 1901-1908
14. Serrador J.M., Nieto M., Alonso-Lebrero J.L., et al. CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood 91 12 (1998) 4632-4644
15. Moody A.M., North S.J., Reinhold B., et al. Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. J Biol Chem 278 9 (2003) 7240-7246
16. Alvarez G., Lascurain R., Hernandez-Cruz P., et al. Differential O-glycosylation in cortical and medullary thymocytes. Biochim Biophys Acta 1760 8 (2006) 1235-1240
17. Tsuboi S., and Fukuda M. Overexpression of branched O-linked oligosaccharides on T cell surface glycoproteins impairs humoral immune responses in transgenic mice. J Biol Chem 273 46 (1998) 30680-30687
18. Zhang J., Shehabeldin A., da Cruz L.A., et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med 190 9 (1999) 1329-1342]
19. Ellies L.G., Tao W., Fellinger W., Teh H.S., and Ziltener H.J. The CD43 130 kD peripheral T-cell activation antigen is downregulated in thymic positive selection. Blood 88 5 (1996) 1725-1732
20. Hernandez J.D., Nguyen J.T., He J., et al. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death. J Immunol 177 8 (2006) 5328-5336
21. Ohara T., Koyama K., Kusunoki Y., et al. Memory functions and death proneness in three CD4 + CD45RO + human T cell subsets. J Immunol 169 1 (2002) 39-48
22. Higashi N., Wu K., Gronhoj Larsen C., et al. Expression and function of CD43 and CDw60 on T cells from patients with atopic dermatitis. Acta Derm Venereol 81 4 (2001) 263-267
23. Fuhlbrigge R.C., King S.L., Sackstein R., and Kupper T.S. CD43 is a ligand for E-selectin on CLA + human T cells. Blood 107 4 (2006) 1421-1426
24. Eda S., Yamanaka M., and Beppu M. Carbohydrate-mediated phagocytic recognition of early apoptotic cells undergoing transient capping of CD43 glycoprotein. J Biol Chem 279 7 (2004) 5967-5974
25. Giordanengo V., Limouse M., Desroys du Roure L., et al. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals. Blood 86 6 (1995) 2302-2311
26. Pallant A., Eskenazi A., Mattei M.G., et al. Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc Natl Acad Sci USA 86 4 (1989) 1328-1332
27. Hara T., Yamauchi M., Takahashi E., et al. The UDP-galactose translocator gene is mapped to band Xp11.23-p 11.22 containing the Wiskott-Aldrich syndrome locus. Somat Cell Mol Genet 19 6 (1993) 571-575
28. Guillen E., Abeijon C., and Hirschberg C.B. Mammalian Golgi apparatus UDP-N-acetylglucosamine transporter: molecular cloning by phenotypic correction of a yeast mutant. Proc Natl Acad Sci USA 95 14 (1998) 7888-7892
29. Sun B., Ranish J.A., Utleg A.G., et al. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol Cell Proteomics 6 1 (2007) 141-149
30. Charrier S., Dupre L., Scaramuzza S., et al. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther 14 5 (2007) 415-428
31. Huang M.M., Tsuboi S., Wong A., et al. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins. Gene Ther 7 4 (2000) 314-320
32. Fukuoka M., Fukudome K., Yamashita Y., Tokushima M., Miyake K., and Kimoto M. Antiadhesive function of 130 kD glycoform of CD43 expressed in CD4 T-lymphocyte clones and transfectant cell lines. Blood 96 13 (2000) 4267-4275
33. Ribeiro R.M., and Perelson A.S. Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) data. Immunol Rev 216 (2007) 21-34